Public company
Tempest Therapeutics, Inc.
TPSTCIK 0001544227
Price$0.36
1 year-96.2%
Disclosed transactions3
Buys / sells1 / 0
Max Insider Score47
Connections with evidence3
TPST · disclosed activity on price
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 47 | Angel MatthewDirector, CEO and President, 10% Owner | TPSTTempest Therapeutics, Inc. Open-market purchase | BUY | $500K 231.5K sh |
Verified connections
- In industryevidencePharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
- ← Insider ofevidenceAngel MatthewDirector, CEO and President, 10% Owner · Feb 6, 2026
- ← Insider ofevidenceSimantov RonitDirector · Jan 28, 2026